As mentioned, it is a GLP-1 agonist, meaning it works synergistically with the GLP-1 hormone to increase its levels
The researchers were careful to note that the data does not prove these symptoms are caused by the medications
The authors searched for randomised clinicals trials of GLP-1 RA medications (albiglutide, dulaglutide, exenatide, liraglutide, lixisenatide, or semaglutide) that also reported adverse events of gallbladder or biliary diseases
MedVi Costs MedVi is fairly new in the GLP-1 marketplace Founded in 2024, MedVi is a telehealth platform that focuses exclusively on getting patients access to GLP-1 medications for weight loss, like compounded semaglutide and tirzepatide
Vyvanse is FDA-approved for binge eating disorder
Any health concerns discussed here should be evaluated and managed by a qualified healthcare provider